Advances in testing techniques are being predicted as moonshot byproducts.
Advanced testing technologies will keep the federal initiative on course.
Rising diabetes rates are raising concern on a global scale.
Managing test utilization is revealing opportunities for improved laboratory performance and better patient care.
CDC has formalized new guidelines aimed at curbing misuse of prescription opioids.